The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

被引：0
|
作者：
Kongju Wu
Ming Yi
Shuang Qin
Qian Chu
Xinhua Zheng
Kongming Wu
机构：
[1] Medical School of Pingdingshan University,Department of Clinical Medicine
[2] Huazhong University of Science and Technology,Department of Oncology, Tongji Hospital of Tongji Medical College
来源：
Experimental Hematology & Oncology | / 8卷
关键词：
Immunotherapy; PD-1; PD-L1; CTLA-4; Immune checkpoint inhibitor; Combination therapy; Meta-analysis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and safety of PD-1 inhibitors for treating advanced melanoma: a systematic review and meta-analysis
    Li, Jing
    Gu, Jian
    IMMUNOTHERAPY, 2018, 10 (15) : 1293 - 1302
  • [22] Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?-A trial-level meta-analysis in PD-L1 selected subgroups
    Passiglia, Francescoy
    Galvano, Antonio
    Barraco, Nadia
    Castiglia, Marta
    Perez, Alessandro
    La Mantia, Maria
    Russo, Antonio
    Bazan, Viviana
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3106 - +
  • [23] Inhibiting CTLA-4 and PD-1 Boosts Response
    不详
    CANCER DISCOVERY, 2013, 3 (07) : 710 - 711
  • [24] Uveal consequences of CTLA-4 and PD-1 inhibition
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [25] The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis
    Xiao, Bo-Ya
    Lin, Guo-He
    Zhao, Yan-Xia
    Wang, Bi-Cheng
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (06) : 3804 - 3818
  • [26] The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review
    Si Chen
    Yuan Li
    Chuiwen Deng
    Jing Li
    Xiaoting Wen
    Ziyan Wu
    Chaojun Hu
    Shulan Zhang
    Ping Li
    Xuan Zhang
    Fengchun Zhang
    Yongzhe Li
    Rheumatology International, 2016, 36 : 33 - 44
  • [27] PD-1, CTLA-4 Point to Drug Response
    Landhuis, Esther
    CANCER DISCOVERY, 2016, 6 (11) : 1201 - 1201
  • [28] The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review
    Chen, Si
    Li, Yuan
    Deng, Chuiwen
    Li, Jing
    Wen, Xiaoting
    Wu, Ziyan
    Hu, Chaojun
    Zhang, Shulan
    Li, Ping
    Zhang, Xuan
    Zhang, Fengchun
    Li, Yongzhe
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (01) : 33 - 44
  • [29] Efficacy of PD-1 and PD-L1 inhibitors in older adults: A meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    Rahma, Osama E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    McCleary, Nadine Jackson
    Ott, Patrick
    Hodi, F. Stephen
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
12345